Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-024858
Filing Date
2025-08-19
Accepted
2025-08-19 17:15:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 2568739
2 GRAPHIC form424b3_001.jpg GRAPHIC 4839
3 GRAPHIC form10-k_001.jpg GRAPHIC 52967
4 GRAPHIC form10-k_002.jpg GRAPHIC 36311
  Complete submission text file 0001641172-25-024858.txt   2699771
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284569 | Film No.: 251232899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)